Nimbex

Active Ingredient(s): Cisatracurium
FDA Approved: * December 15, 1995
Pharm Company: * ABBOTT
Category: Muscle Relaxer

Cisatracurium besilate (INN; cisatracurium besylate (USAN); formerly recognized as 51W89;[1] trade name Nimbex) is a bisbenzyltetrahydroisoquinolinium that has effect as a neuromuscular-blocking drug non-depolarizing neuromuscular-blocking drugs, used adjunctively in anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. It shows intermediate duration of action. Cisatracurium is one of the ten isome... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Nimbex 2 mg/ml Intravenous Injection
NDC: 0074-4378
Labeler:
Abbvie Inc.
Nimbex 2 mg/ml Intravenous Injection
NDC: 0074-4380
Labeler:
Abbvie Inc.
Nimbex 10 mg/ml Intravenous Injection
NDC: 0074-4382
Labeler:
Abbvie Inc.